Search Results 101-110 of 16293 for Solodyn
About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...
Inclusion Criteria: Diagnosis of Crohn's disease (CD) for at least 90 days, confirmed by endoscopy during the Screening Period.
About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-C137 in ...
Strelow B, Herndon J, McMahon A, Takagi M, McCoy R, Olson R, O'Laughlin D. Improved Diabetes Screening for Women After Gestational Diabetes Mellitus.
Dr. Roberts' laboratory has made major, unique and widely acknowledged contributions to the understanding and treatment of hepatocellular.
Inclusion Criteria: Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements ...
Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving selinexor, carfilzomib, and dexamethasone may be ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.